NCT02400476 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 137
- group Id
- BG001
- value
- 64
- group Id
- BG002
- value
- 136
- group Id
- BG003
- value
- 104
- group Id
- BG004
- value
- 60
- group Id
- BG005
- value
- 62
- group Id
- BG006
- value
- 563
- units
- Participants
- groups
- description
- 240 mg Neratinib orally once daily with food for thirteen 28-day cycles. Loperamide daily for two 28-day cycles and then as needed. Neratinib Loperamide
- id
- BG000
- title
- Loperamide
- description
- 240 mg Neratinib orally once daily with food for thirteen 28-day cycles. Anti-inflammatory treatment for 1 cycle and Loperamide to be administered daily for two 28-day cycles and then as needed, thereafter. Neratinib Loperamide Budesonide: 9 mg extended release tablets once daily with or without food for 28 days
- id
- BG001
- title
- Budesonide and Loperamide
- description
- 240 mg Neratinib orally once daily with food for thirteen 28-day cycles. Colestipol for 1 cycle and loperamide to be administered 1 cycle and then as needed, thereafter. Neratinib Loperamide Colestipol: 2 g twice daily with or without food for one 28 day cycle
- id
- BG002
- title
- Colestipol and Loperamide
- description
- 240 mg Neratinib orally once daily with food for thirteen 28-day cycles. Colestipol for 1 cycle and loperamide to be administered as needed. Neratinib Loperamide Colestipol: 2 g twice daily with or without food for one 28 day cycle
- id
- BG003
- title
- Colestipol With Loperamide as Needed
- description
- 120 mg Neratinib for Week 1, followed by 160 mg Neratinib starting for Week 2, followed by 240 mg Neratinib starting at Week 3 and thereafter (C1D15 to End of Treatment). Loperamide administered as needed. Neratinib Loperamide
- id
- BG004
- title
- Neratinib Dose Escalation 1
- description
- 160 mg neratinib for the first 2 weeks, followed by 200 mg neratinib for the next 2 weeks, followed by 240 mg neratinib thereafter (C2D1 to End of treatment. Loperamide will be administered on an as-needed basis only. Neratinib Loperamide
- id
- BG005
- title
- Neratinib Dose Escalation 2
- description
- Total of all reporting groups
- id
- BG006
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 116
- group Id
- BG001
- value
- 58
- group Id
- BG002
- value
- 117
- group Id
- BG003
- value
- 93
- group Id
- BG004
- value
- 51
- group Id
- BG005
- value
- 52
- group Id
- BG006
- value
- 487
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 19
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 9
- group Id
- BG005
- value
- 10
- group Id
- BG006
- value
- 76
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.06
- value
- 53.39
- group Id
- BG001
- spread
- 10.55
- value
- 49.11
- group Id
- BG002
- spread
- 11.08
- value
- 52.49
- group Id
- BG003
- spread
- 10.23
- value
- 51.94
- group Id
- BG004
- spread
- 10.71
- value
- 51.90
- group Id
- BG005
- spread
- 10.15
- value
- 53.82
- group Id
- BG006
- spread
- 10.76
- value
- 52.31
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 137
- group Id
- BG001
- value
- 64
- group Id
- BG002
- value
- 133
- group Id
- BG003
- value
- 104
- group Id
- BG004
- value
- 60
- group Id
- BG005
- value
- 62
- group Id
- BG006
- value
- 560
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 3
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 113
- group Id
- BG001
- value
- 50
- group Id
- BG002
- value
- 96
- group Id
- BG003
- value
- 80
- group Id
- BG004
- value
- 53
- group Id
- BG005
- value
- 52
- group Id
- BG006
- value
- 444
- title
- White
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 36
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 13
- group Id
- BG003
- value
- 9
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 38
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 2
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 4
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 18
- title
- Other
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 5
- title
- Unknown
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 1
- title
- Missing
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 6
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 15
- title
- Not Reported
- title
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 10
- group Id
- BG004
- value
- 6
- group Id
- BG005
- value
- 7
- group Id
- BG006
- value
- 27
- title
- Canada
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 4
- title
- Austria
- categories
- measurements
- group Id
- BG000
- value
- 132
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 115
- group Id
- BG003
- value
- 83
- group Id
- BG004
- value
- 20
- group Id
- BG005
- value
- 11
- group Id
- BG006
- value
- 413
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 17
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 23
- group Id
- BG005
- value
- 18
- group Id
- BG006
- value
- 86
- title
- Australia
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 6
- group Id
- BG006
- value
- 6
- title
- France
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 2
- title
- Germany
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 11
- group Id
- BG005
- value
- 14
- group Id
- BG006
- value
- 25
- title
- Spain
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 137
- group Id
- BG001
- value
- 64
- group Id
- BG002
- value
- 136
- group Id
- BG003
- value
- 104
- group Id
- BG004
- value
- 60
- group Id
- BG005
- value
- 62
- group Id
- BG006
- value
- 563
- units
- Participants
- groups
- description
- 240 mg Neratinib orally once daily with food for thirteen 28-day cycles. Loperamide daily for two 28-day cycles and then as needed. Neratinib Loperamide
- id
- BG000
- title
- Loperamide
- description
- 240 mg Neratinib orally once daily with food for thirteen 28-day cycles. Anti-inflammatory treatment for 1 cycle and Loperamide to be administered daily for two 28-day cycles and then as needed, thereafter. Neratinib Loperamide Budesonide: 9 mg extended release tablets once daily with or without food for 28 days
- id
- BG001
- title
- Budesonide and Loperamide
- description
- 240 mg Neratinib orally once daily with food for thirteen 28-day cycles. Colestipol for 1 cycle and loperamide to be administered 1 cycle and then as needed, thereafter. Neratinib Loperamide Colestipol: 2 g twice daily with or without food for one 28 day cycle
- id
- BG002
- title
- Colestipol and Loperamide
- description
- 240 mg Neratinib orally once daily with food for thirteen 28-day cycles. Colestipol for 1 cycle and loperamide to be administered as needed. Neratinib Loperamide Colestipol: 2 g twice daily with or without food for one 28 day cycle
- id
- BG003
- title
- Colestipol With Loperamide as Needed
- description
- 120 mg Neratinib for Week 1, followed by 160 mg Neratinib starting for Week 2, followed by 240 mg Neratinib starting at Week 3 and thereafter (C1D15 to End of Treatment). Loperamide administered as needed. Neratinib Loperamide
- id
- BG004
- title
- Neratinib Dose Escalation 1
- description
- 160 mg neratinib for the first 2 weeks, followed by 200 mg neratinib for the next 2 weeks, followed by 240 mg neratinib thereafter (C2D1 to End of treatment. Loperamide will be administered on an as-needed basis only. Neratinib Loperamide
- id
- BG005
- title
- Neratinib Dose Escalation 2
- description
- Total of all reporting groups
- id
- BG006
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 116
- group Id
- BG001
- value
- 58
- group Id
- BG002
- value
- 117
- group Id
- BG003
- value
- 93
- group Id
- BG004
- value
- 51
- group Id
- BG005
- value
- 52
- group Id
- BG006
- value
- 487
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 19
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 9
- group Id
- BG005
- value
- 10
- group Id
- BG006
- value
- 76
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.06
- value
- 53.39
- group Id
- BG001
- spread
- 10.55
- value
- 49.11
- group Id
- BG002
- spread
- 11.08
- value
- 52.49
- group Id
- BG003
- spread
- 10.23
- value
- 51.94
- group Id
- BG004
- spread
- 10.71
- value
- 51.90
- group Id
- BG005
- spread
- 10.15
- value
- 53.82
- group Id
- BG006
- spread
- 10.76
- value
- 52.31
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 137
- group Id
- BG001
- value
- 64
- group Id
- BG002
- value
- 133
- group Id
- BG003
- value
- 104
- group Id
- BG004
- value
- 60
- group Id
- BG005
- value
- 62
- group Id
- BG006
- value
- 560
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 3
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 113
- group Id
- BG001
- value
- 50
- group Id
- BG002
- value
- 96
- group Id
- BG003
- value
- 80
- group Id
- BG004
- value
- 53
- group Id
- BG005
- value
- 52
- group Id
- BG006
- value
- 444
- title
- White
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 36
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 13
- group Id
- BG003
- value
- 9
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 38
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 2
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 4
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 18
- title
- Other
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 5
- title
- Unknown
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 1
- title
- Missing
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 6
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 15
- title
- Not Reported
- title
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 10
- group Id
- BG004
- value
- 6
- group Id
- BG005
- value
- 7
- group Id
- BG006
- value
- 27
- title
- Canada
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 4
- title
- Austria
- categories
- measurements
- group Id
- BG000
- value
- 132
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 115
- group Id
- BG003
- value
- 83
- group Id
- BG004
- value
- 20
- group Id
- BG005
- value
- 11
- group Id
- BG006
- value
- 413
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 17
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 23
- group Id
- BG005
- value
- 18
- group Id
- BG006
- value
- 86
- title
- Australia
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 6
- group Id
- BG006
- value
- 6
- title
- France
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 2
- title
- Germany
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 11
- group Id
- BG005
- value
- 14
- group Id
- BG006
- value
- 25
- title
- Spain
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle